These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1686352)

  • 41. [The induction of lymphokine-activated killer cells: increased cytotoxicity via long-term cultivation].
    Hartwig M; Körner IJ; Malz W
    Arch Geschwulstforsch; 1989; 59(2):73-7. PubMed ID: 2785787
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A new effective therapy of hairy cell leukemia and other lymphoproliferative diseases].
    Juliusson G; Liliemark J
    Lakartidningen; 1991 Aug; 88(35):2746-9. PubMed ID: 1680209
    [No Abstract]   [Full Text] [Related]  

  • 43. New purine analogues for the treatment of chronic B-cell malignancies.
    Gribbin TE
    Henry Ford Hosp Med J; 1991; 39(2):98-102. PubMed ID: 1679757
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interferon-induced changes in the susceptibility of murine and human lymphoma cells to natural cytotoxic lymphocytes.
    Giuliani-Bonmassar A; Graziani G; Frati L; Bonmassar E
    Int J Tissue React; 1984; 6(1):35-41. PubMed ID: 6585352
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 2',5'-Oligoadenylate trimer core and the cordycepin analog augment the tumoricidal activity of human natural killer cells.
    Black PL; Henderson EE; Pfleiderer W; Charubala R; Suhadolnik RJ
    J Immunol; 1984 Nov; 133(5):2773-7. PubMed ID: 6332860
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recombinant leukocyte A interferon in Kaposi's sarcoma.
    Krown SE; Real FX; Krim M; Cunningham-Rundles S; Koziner B; Myskowski PL; Safai B; Oettgen HF
    Ann N Y Acad Sci; 1984; 437():431-8. PubMed ID: 6398651
    [No Abstract]   [Full Text] [Related]  

  • 47. Alpha-interferon induces remission in hairy cell leukemia without enhancement of natural killing.
    Gastl G; Aulitzky W; Leiter E; Flener R; Huber C
    Blut; 1986 May; 52(5):273-9. PubMed ID: 3635416
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of natural killer cytotoxicity by recombinant alpha interferons. Augmentation by IFN-alpha 7, an interferon similar to IFN-alpha J.
    Platsoucas CD; Fox FE; Oleszak E; Fong K; Nanno M; Ioannides CG; Trotta PP
    Anticancer Res; 1989; 9(4):849-58. PubMed ID: 2817813
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Direct suppression of natural killer activity in human peripheral blood leukocyte cultures by glucocorticoids and its modulation by interferon.
    Holbrook NJ; Cox WI; Horner HC
    Cancer Res; 1983 Sep; 43(9):4019-25. PubMed ID: 6871844
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 2-Chlorodeoxyadenosine treatment of lymphoid malignancies.
    Piro LD
    Blood; 1992 Feb; 79(4):843-5. PubMed ID: 1346575
    [No Abstract]   [Full Text] [Related]  

  • 51. [Natural killer cells lysing the blood B-lymphocytes of patients with chronic lympholeukemia].
    Khonina NA; Shubinskiĭ GZ
    Eksp Onkol; 1988; 10(4):44-6. PubMed ID: 3263265
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of natural killer cells in the treatment of chronic myeloid leukemia.
    Silla LM; Whiteside TL; Ball ED
    J Hematother; 1995 Aug; 4(4):269-79. PubMed ID: 7489141
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decitabine has a biphasic effect on natural killer cell viability, phenotype, and function under proliferative conditions.
    Kopp LM; Ray A; Denman CJ; Senyukov VS; Somanchi SS; Zhu S; Lee DA
    Mol Immunol; 2013 Jul; 54(3-4):296-301. PubMed ID: 23328088
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Abrogation of interferon-induced resistance to interferon-activated major histocompatibility complex-unrestricted killers by treatment of a melanoma cell line with 5-fluorouracil.
    Neefe JR; Glass J
    Cancer Res; 1991 Jun; 51(12):3159-63. PubMed ID: 2039994
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Decreased natural killer cell activity after prolonged administration of interferon in cancer patients.
    Bravo Cuellar A; Martin Ruiz JL; Orbach-Arbouys S
    Immunol Lett; 1985; 10(3-4):137-9. PubMed ID: 4044011
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of mevalonic acid in the regulation of natural killer cell cytotoxicity.
    Cutts JL; Scallen TJ; Watson J; Bankhurst AD
    J Cell Physiol; 1989 Jun; 139(3):550-7. PubMed ID: 2738100
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [In vitro effect of alpha-interferon and thymomodulin on natural killer activity in patients with AIDS-related complex].
    Paroli M; Balsano C; Valesini G; Biffoni M; Perrone A; Barnaba V
    Ann Ital Med Int; 1988; 3(1):39-42. PubMed ID: 3152836
    [No Abstract]   [Full Text] [Related]  

  • 58. Natural killer cells in children with malignant solid tumors. Effect of recombinant interferon-alpha and interleukin-2 on natural killer cell function against tumor cell lines.
    Alvarado CS; Findley HW; Chan WC; Hnath RS; Abdel-Mageed A; Pais RC; Kutner MH; Ragab AH
    Cancer; 1989 Jan; 63(1):83-9. PubMed ID: 2783377
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhancement of natural killer cell activity by interferon and interleukin-2 in human large granular lymphocytes inhibited by cyclosporine.
    Ramsey KM; Dyer D; Stocks N; Djeu JY
    Transplant Proc; 1984 Dec; 16(6):1628-31. PubMed ID: 6334388
    [No Abstract]   [Full Text] [Related]  

  • 60. The mechanism of 2-chlorodeoxyadenosine-induced cell death.
    Wataya Y; Hirota Y; Hiramoto-Yoshioka A; Tanaka S; Otani T; Minowada J; Matsuda A; Ueda T
    Adv Exp Med Biol; 1989; 253B():227-34. PubMed ID: 2575349
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.